Results 241 to 250 of about 13,619,962 (300)

Interleukin-4 and Interleukin-17 are associated with coronary artery disease. [PDF]

open access: yesClin Cardiol
Wang C   +13 more
europepmc   +1 more source

Interleukin 4

International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1990
Since its discovery in 1982, numerous biological activities of interleukin-4 (IL-4) have been described. Like other cytokines, IL-4 is highly pleiotropic, both with respect to the number of different target cells that are responsive to it and with respect to the number of different biological responses it elicits.
J H, Jansen   +3 more
  +6 more sources

Interleukin‐4 and listeriosis

Immunological Reviews, 1997
Summary: Experimental infection of mice with Listeria monocytogenes (L. monocytogenes) has served as an appropriate model for analyzing Thl nil driven immune responses. Generally, Th2 responses are absent and IL‐4 is not detectable. Here, we describe experimental settings under which IL‐4 is detectable in listeriosis.
Kaufmann, S.   +4 more
openaire   +3 more sources

Interleukin‐4 and the interleukin‐4 receptor in allergic contact dermatitis

Contact Dermatitis, 1998
Cutaneous immune responses involving T helper (TH) type 1 (TH1) and type 2 (TH2) T cells, characterised by secretion of interferon‐γ (Ifn‐γ) and interleukin‐4 (IL‐4), respectively, have both been reported in allergic contact dermatitis (ACD). We used immunohistochemistry to localize expression of IL‐4 in ACD lesions and unaffected skin.
A, Rowe, C B, Bunker
openaire   +2 more sources

Regulation of Interleukin 4 Production and of Interleukin 4-Producing Cells

International Archives of Allergy and Immunology, 2009
Interleukin 4 (IL-4) is a cytokine with a broad range of functions on immune cells including the stimulation of IgE synthesis by B cells. IL-4 is synthesized by freshly isolated T cells following appropriate stimulation with either lectins or antibodies against selected surface antigens.
openaire   +2 more sources

Interleukin-4 as a therapeutic target

Pharmacology & Therapeutics, 2023
Interleukin-4 (IL-4) is a pleiotropic cytokine mainly known for its role in type 2 immunity. Therapies antagonizing or blocking IL-4 activity have been developed to counteract diseases such as atopic dermatitis and asthma. In contrast, other disorders experimentally benefit from IL-4-related effects and IL-4 recently demonstrated beneficial activity in
Yvonne, Gärtner   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy